Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 2 (1)

Trial Status

Recruiting3
Terminated1

Clinical Trials (4)

Showing 4 of 4 trials
NCT04057638Not ApplicableRecruiting

Craniomaxillofacial and Upper Extremity Allotransplantation

NCT05362370Recruiting

Stryker PEEK Customized Implant: A Prospective Post Market Follow Up to Evaluate Safety, Performance and Effectiveness

NCT01889381Phase 2Recruiting

Human Craniomaxillofacial Allotransplantation

NCT01633892Not ApplicableTerminatedPrimary

Use of Concentrated Endogenous Autologous Adipose Stromal Cells in Fat Grafts for Craniofacial Trauma

Showing all 4 trials

Research Network

Activity Timeline